Wednesday, 29 March 2017

Worldwide Antibodies Production Market Shines Amid Growing Prevalence of Serious Diseases

Transparency Market Research reveals its projections for all companies associated with antibody production in a report titled “Antibody Production Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023.” The report can help a user be more careful and knowledgeable on the market projections and act accordingly. It therefore helps users reduce the chances of negative business decisions and promotes a healthier competitive spirit.

The primary factor governing the overall growth rate of the global antibodies production market is the growing prevalence of the diseases that can be fought by speeding up the development in this market. Antibody production research and development has attracted many medical personnel and biological scientists due to the immense benefits that this market’s growth can provide to all of the healthcare industry.

Antibodies possess the incredibly valuable property of targeting specific cells. This allows the global antibodies production market to be a highly potential holder of the cure to cancer. This is reflected in the immense research and development in antibody production that is aimed at improving cancer treatments. A majority of the cancer-based research in the global antibodies production market has led to the large-scale production of monoclonal antibodies which can be replicated in laboratories. Another factor benefitting the global antibodies production market is the growing number of antibody drug conjugates that are currently under clinical trials. The global antibodies production market will, however, continue to be hampered by the high cost of development of antibody production methods and the low number of antibodies that are being made commercially available.

North America holds a dominant share in the global antibodies production market at the moment. This region – especially the U.S. – holds a very high rate of research and innovation in biotechnology and pharmaceuticals through the presence of several globally prominent players from both industries. These companies have consistently been at the forefront of the development cycle in the global antibodies production market and the developments for related therapeutic procedures and drugs. On the other hand, Asia Pacific is showing a strong increase in its demand for antibodies production options due to a heavy demand for cost-effective treatment options for the increasingly prevalent chronic diseases.

The global antibodies production market is usually segmented on the basis of antibody types and their applications. The two key groups of antibodies are monoclonal and polyclonal antibodies. The former includes the sub-segments of murine, chimeric, and humanized antibodies. The applications based on the global antibodies production market include transplantation, hematology/oncology, cardiology, infections, rheumatology, and gastroenterology.

The key players in the global antibodies production market include Merck Millipore, GeneTex, Inc., GE Healthcare, Genentech, Thermo Fisher Scientific, Inc., Abbott Laboratories, Eli Lilly and Company, Sigma-Aldrich Corporation, Abcam plc, and Roche Diagnostics Corporation.

Fill the form for an exclusive sample of this report @

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

No comments:

Post a Comment